The market for GI Stool Testing Market is expected to reach US$ XX Mn By 2026.
Stool tests are performed to diagnose G.I. tract disorders and aid in the detection of parasite infection, bleeding obstruction, and inflammation. Stool tests can also be used to diagnose colorectal cancer or the presence of pathogens in the G.I. tract, such as rotavirus, C. difficile, and H. pylori. Laboratory tests used for stool testing are either microbial particle-based or antibody-based, which include chemiluminescence immunoassays (CLIA), immunoassays, and molecular diagnostic testing.
The increased prevalence of Clostridium difficile infections and other gastrointestinal diseases drives the global G.I. stool testing market. According to the Centers for Disease Control and Prevention, in 2014, an estimated 14.8 million adults were diagnosed with ulcers and other digestive disorders in the United States. Furthermore, in 2017, 135,430 new cases of colorectal cancer were diagnosed in the country, raising the demand for G.I. stool testing. However, the challenge of accurate testing restrains the market.
The global G.I. stool testing market is segmented based on product type, application, test type, end-user, and geography. Among product types, the reagents segment dominated the global market in 2017 with over 60% of the market share. Among applications, the G.I. tract infections segment led the global market in 2017 owing to the high prevalence of cases and increased awareness regarding gastrointestinal disorders. Based on end-users, hospitals will continue to dominate the market owing to the high procedural load of the tests.
North America is anticipated to lead the global market owing to the high awareness of gastrointestinal disorders and the availability of an evolved healthcare infrastructure. Manufacturers are focusing on emerging markets, including those in Asia-Pacific and Latin America, due to the presence of potential opportunities.
Global G.I. Stool Testing Market by Product Type, 2016-2026 (in millions of U.S. dollars)
Global G.I. Stool Testing Market by Application (US$ Mn), 2016-2026
Global G.I. Stool Testing Market by Test Type (US$ Mn), 2016-2026
End-User Global G.I. Stool Testing Market, 2016-2026 (US$ Mn)
Global G.I. Stool Testing Market by Geography (US$ Mn), 2016-2026
Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., BioMrieux, Inc., Bio-Rad Laboratories, Cenegenics Corporation, DiaSorin S.p.A., Meridian Bioscience, Inc., Quest Diagnostics Incorporated, and Siemens Healthcare
The market for GI Stool Testing Market is expected to reach US$ XX Mn By 2026.
The GI Stool Testing Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., BioMrieux, Inc., Bio-Rad Laboratories, Cenegenics Corporation, DiaSorin S.p.A., Meridian Bioscience, Inc., Quest Diagnostics Incorporated are some of the major players in the global market.